JOSH LITTELL: Open Payments
NPI 1386322147 · CLEVELAND, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,291 in 63 payments from 17 companies in 2025. Trend: 2023 $234 · 2024 $1,526 · 2025 $1,291
Food & beverage: $1,275Education: $17
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 9 | $174 |
| Travere Therapeutics, Inc. | 6 | $151 |
| AstraZeneca Pharmaceuticals LP | 7 | $145 |
| Otsuka America Pharmaceutical, Inc. | 6 | $141 |
| Vifor Pharma, Inc. | 5 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $109 |
| Amgen Inc. | 5 | $77 |
| Ardelyx, Inc. | 3 | $63 |
| SCPHARMACEUTICALS INC. | 4 | $61 |
| ANI Pharmaceuticals, Inc. | 2 | $51 |
Products named: VELPHORO, FARXIGA, Veltassa, JYNARQUE, Kerendia, TAVNEOS, IBSRELA, FUROSCIX.
Industry payments across TN — which companies pay providers there.
